1.Repetitive Nerve Stimulation in MuSK-Antibody-Positive Myasthenia Gravis.
Seung Woo KIM ; Mun Kyung SUNWOO ; Seung Min KIM ; Ha Young SHIN ; Il Nam SUNWOO
Journal of Clinical Neurology 2017;13(3):287-292
BACKGROUND AND PURPOSE: Responses to repetitive nerve stimulation (RNS) in patients with muscle-specific tyrosine kinase (MuSK) antibody (Ab)-positive myasthenia gravis (MG) vary depending on the muscles tested. We analyzed the RNS responses of limb and facial muscles in MuSK-Ab-positive and acetylcholine receptor (AChR)-Ab-negative MG (MuSK MG) and MuSK-Ab-negative and AChR-Ab-negative [double-seronegative (DSN)] MG patients. METHODS: We retrospectively compared RNS responses between 45 MuSK MG and 29 DSN MG. RNS was applied to the abductor digiti minimi, flexor carpi ulnaris, trapezius, orbicularis oculi, and nasalis muscles. RESULTS: Abnormal RNS responses in limb muscles were observed in 22.2 and 58.6% of MuSK MG and DSN MG patients, respectively, with abnormal facial responses observed in 77.8 and 65.5%, and abnormal responses observed in any of the five muscles in 86.7 and 72.4%. Abnormal RNS responses in the abductor digiti minimi or flexor carpi ulnaris were less frequent in MuSK MG (8.9 and 15.6%, respectively) than in DSN MG (37.9 and 55.2%), whereas the findings for other muscles were not significantly different between the groups. Abnormal facial responses but normal limb responses were independently associated with MuSK MG (odds ratio=5.224, 95% confidence interval=1.300–20.990). CONCLUSIONS: Abnormal RNS responses primarily in facial muscles without involvement of limb muscles were more pronounced in MuSK MG than in DSN MG. RNS of both facial and limb muscles in AChR-Ab-negative MG can increase the test sensitivity and aid in early suspicion of MuSK MG.
Acetylcholine
;
Extremities
;
Facial Muscles
;
Humans
;
Muscles
;
Myasthenia Gravis*
;
Protein-Tyrosine Kinases
;
Retrospective Studies
;
Superficial Back Muscles
2.A Case of Posterior Reversible Encephalopathy Syndrome with Similar Symptoms as Transient Global Amnesia.
Jeongyeon KIM ; Young Ik JUNG ; Junghee SEO ; Heejin LEE ; Mun Kyung SUNWOO
Dementia and Neurocognitive Disorders 2018;17(4):176-178
No abstract available.
Amnesia, Transient Global*
;
Posterior Leukoencephalopathy Syndrome*
3.The MMSE and MoCA for Screening Cognitive Impairment in Less Educated Patients with Parkinson's Disease.
Ji In KIM ; Mun Kyung SUNWOO ; Young H SOHN ; Phil Hyu LEE ; Jin Y HONG
Journal of Movement Disorders 2016;9(3):152-159
OBJECTIVE: To explore whether the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) can be used to screen for dementia or mild cognitive impairment (MCI) in less educated patients with Parkinson's disease (PD). METHODS: We reviewed the medical records of PD patients who had taken the Korean MMSE (K-MMSE), Korean MoCA (K-MoCA), and comprehensive neuropsychological tests. Predictive values of the K-MMSE and K-MoCA for dementia or MCI were analyzed in groups divided by educational level. RESULTS: The discriminative powers of the K-MMSE and K-MoCA were excellent [area under the curve (AUC) 0.86–0.97] for detecting dementia but not for detecting MCI (AUC 0.64–0.85). The optimal screening cutoff values of both tests increased with educational level for dementia (K-MMSE < 15 for illiterate, < 20 for 0.5–3 years of education, < 23 for 4–6 years, < 25 for 7–9 years, and < 26 for 10 years or more; K-MoCA < 7 for illiterate, < 13 for 0.5–3 years, < 16 for 4–6 years, < 19 for 7–9 years, < 20 for 10 years or more) and MCI (K-MMSE < 19 for illiterate, < 26 for 0.5–3 years, < 27 for 4–6 years, < 28 for 7–9 years, and < 29 for 10 years or more; K-MoCA < 13 for illiterate, < 21 for 0.5–3 years, < 23 for 4–6 years, < 25 for 7–9 years, < 26 for 10 years or more). CONCLUSION: Both MMSE and MoCA can be used to screen for dementia in patients with PD, regardless of educational level; however, neither test is sufficient to discriminate MCI from normal cognition without additional information.
Cognition
;
Cognition Disorders*
;
Dementia
;
Education
;
Humans
;
Mass Screening*
;
Medical Records
;
Methylenebis(chloroaniline)*
;
Mild Cognitive Impairment
;
Neuropsychological Tests
;
Parkinson Disease*
4.Parkinsonism Associated with Glucocerebrosidase Mutation.
Mun Kyung SUNWOO ; Seung Min KIM ; Sarah LEE ; Phil Hyu LEE
Journal of Clinical Neurology 2011;7(2):99-101
BACKGROUND: Gaucher's disease is an autosomal recessive, lysosomal storage disease caused by mutations of the beta-glucocerebrosidase gene (GBA). There is increasing evidence that GBA mutations are a genetic risk factor for the development of Parkinson's disease (PD). We report herein a family of Koreans exhibiting parkinsonism-associated GBA mutations. CASE REPORT: A 44-year-old woman suffering from slowness and paresthesia of the left arm for the previous 1.5years, visited our hospital to manage known invasive ductal carcinoma. During a preoperative evaluation, she was diagnosed with Gaucher's disease and double mutations of S271G and R359X in GBA. Parkinsonian features including low amplitude postural tremors, rigidity, bradykinesia and shuffling gait were observed. Genetic analysis also revealed that her older sister, who had also been diagnosed with PD and had been taking dopaminergic drugs for 8-years, also possessed a heterozygote R359X mutation in GBA. 18F-fluoropropylcarbomethoxyiodophenylnortropane positron-emission tomography in these patients revealed decreased uptake of dopamine transporter in the posterior portion of the bilateral putamen. CONCLUSIONS: This case study demonstrates Korean familial cases of PD with heterozygote mutation of GBA, further supporting the association between PD and GBA mutation.
Adult
;
Arm
;
Carcinoma, Ductal
;
Dopamine Agents
;
Dopamine Plasma Membrane Transport Proteins
;
Female
;
Gait Disorders, Neurologic
;
Gaucher Disease
;
Glucosylceramidase
;
Heterozygote
;
Humans
;
Hypokinesia
;
Lysosomal Storage Diseases
;
Paresthesia
;
Parkinson Disease
;
Parkinsonian Disorders
;
Positron-Emission Tomography
;
Risk Factors
;
Siblings
;
Stress, Psychological
;
Tremor
5.Will Hypomagnesemia Induce Benign Eyelid Myokymia?
Jeongyeon KIM ; Sung Wook HYUNG ; Sun Kyu HAN ; Jae Yong LEE ; Hyun-Jeong YU ; Mun Kyung SUNWOO
Korean Journal of Health Promotion 2021;21(4):129-133
Background:
Myokymia consists of involuntary, fine, continuous contraction that spread across the affected striated muscle. Eyelid myokymia, unlike other dystonic facial contracture such as blepharospasm and hemifacial spasm, is assumed to be a benign, self-limited disorder. Eyelid myokymia is associated with stress, fatigue, excercise, and exccessive caffeine use. The pathophysiology is not well understood, but some drugs or brain structural lesions are the cause of the eyelid myokymia. Especially in Korea hypomagnesemia is generally known the main cause of eyelid myokymia, however there are no evidences so far. This study investigated the relation between eyelid myokymia and serum magnesium level.
Methods:
We performed a cross sectional study on 72 patients with myokymia and 197 controls. We investigated fatigue, sleep quality, alcohol, smoking, caffeine use, and exercise datas by interview. We analyzed laboratory datas including magnesium, calcium, phosphate, thyroid hormone in serum.
Results:
Demographic characteristics between the patients with myokymia and controls showed no significant differences in age, gender, smoking, and alcohol history. Fatigue and poor sleep quality were significantly higher in the myokymia group than control group. However, any laboratory results including magnesium showed no significant differences between two groups.
Conclusions
These data suggested that the eyelid myokymia is not related to the serum magnesium level as well as calcium and phosphate. Only fatigue and sleep quality were shown the relationship with eyelid myokymia.
7.Is the Presence of Headache Indispensable in Diagnosing Reversible Cerebral Vasoconstriction Syndrome?
Byung Su KIM ; Yun Kyung PARK ; Mun Kyung SUNWOO ; Hyun Jeung YU ; Eun Hye JEONG ; Dae Yoon KIM
Journal of Clinical Neurology 2019;15(4):588-590
No abstract available.
Headache
;
Vasoconstriction
8.Validation of MoCA-MMSE Conversion Scales in Korean Patients with Cognitive Impairments.
Young Ik JUNG ; Eun Hye JEONG ; Heejin LEE ; Junghee SEO ; Hyun Jeong YU ; Jin Y HONG ; Mun Kyung SUNWOO
Dementia and Neurocognitive Disorders 2018;17(4):148-155
BACKGROUND AND PURPOSE: Two conversion scales between the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) have been validated for Korean patients with Parkinson's disease. The aim of the present study was to validate these conversion scales for all patients with cognitive impairments regardless of dementia subtype. METHODS: Medical records of 323 subjects who completed both MMSE and MoCA on the same day were retrospectively reviewed. Mean, median, and root mean squared error (RMSE) of the difference between true and equivalent MMSE scores were calculated. Intraclass correlation coefficients (ICCs) between true and equivalent MMSE scores were also calculated. The validity of MoCA-MMSE conversion scales was evaluated according to educational level (low educated: ≤6 years; high educated: ≥7 years) and subtypes of cognitive impairment. RESULTS: The difference between true and equivalent MMSE scores had a median value of 0, a mean value of 0.19 according to the van Steenoven scale, a mean value of 0.57 according to the Lawton scale, RMSE value of 2.2 according to the van Steenoven scale, and RMSE value of 0.42 according to the Lawton scale. Additionally, ICCs between true and equivalent MMSE scores were 0.92 and 0.90 on van Steenovan and Lawton conversion scales, respectively. These results were maintained in subgroup analyses. CONCLUSIONS: Findings of the present study suggest that both van Steenovan and Lawton MoCA-MMSE conversion scales are applicable to transforming MoCA scores into MMSE scores in patients with cognitive impairments regardless of dementia subtype or educational level.
Cognition Disorders*
;
Dementia
;
Humans
;
Medical Records
;
Methylenebis(chloroaniline)
;
Parkinson Disease
;
Retrospective Studies
;
Weights and Measures*
9.Sleepiness and Depression in Parkinson's Disease Patients Treated with Ropinirole and Levodopa.
Suk Yun KANG ; Ho Sung RYU ; Mun Kyung SUNWOO ; Sang Jin KIM ; Jong Sam BAIK ; Mee Young PARK ; Hyung Eun PARK ; Joong Seok KIM ; Kyum Yil KWON ; Seong Beom KOH ; Young Eun KIM ; Mi Kyong LEE ; Jong Min KIM ; Sun Ju CHUNG ; Young Ho SOHN
Journal of Movement Disorders 2017;10(3):123-129
OBJECTIVE: We aimed to investigate the effect of ropinirole on excessive daytime sleepiness (EDS) and depression in Parkinson’s disease (PD) with a large population. METHODS: We conducted a cross-sectional observational study at nine hospitals in Korea between April 24, 2013, and April 22, 2015. We analyzed the demographic and clinical features, other medical history, history of antiparkinsonian medication within 6 months, Hoehn and Yahr stage (HY stage), Unified Parkinson’s Disease Rating Scale (UPDRS) part II and III, Epworth Sleepiness Scale (ESS), and 30-item Geriatric Depression Scale (GDS-30). RESULTS: Four-hundred-thirteen patients with PD (mean age: 65.2 ± 9.0 years; men: 227 patients) were analyzed. Multivariate logistic regression analysis showed that age at examination, UPDRS II, and GDS-30 were independent risk factors for EDS and that sex, UPDRS II, and ESS were independent risk factors for depression. CONCLUSION: Our large group study did not find any significant associations of ropinirole with EDS and depression in Korean PD patients.
Depression*
;
Humans
;
Korea
;
Levodopa*
;
Logistic Models
;
Male
;
Observational Study
;
Parkinson Disease*
;
Risk Factors